Medpace Holdings Inc filed a Form 4 report for the period ending 25 September 2026, submitted on 25 October 2026 at 06:50 pm. The filing was made by August J. Troendle, who serves as Director, President & Chief Executive Officer and holds a 10 percent ownership stake in the company. No specific transaction details, such as share purchases or sales, were disclosed in the excerpt. On the same day, Medpace’s stock (ticker MEDP) recorded a price increase of 2.33 percent, as indicated by the notation “MEDP+2.33%”. The announcement was posted on Reuters’ stock market feed at 06:50 pm.